News Overview

The Board of Directors are further scheduled to meet on January 28, 2022 to consider subdivision (split) of equity shares of the company.

The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval

Net Profit down 16.7%

Business Wire India Ekata, a global leader in digital identity verification, today expanded its account opening solutions to help online businesses worldwide quickly identify and flag risky account sign-ups. Powered by a proprietary data set and machine learning, Ekata’s account opening solutions assess the risk of new accounts in real-time, enabling businesses to create streamlined onboarding experiences for legitimate customers and reject or add friction […]

New Zealand food prices climbed 4.5 percent on year in December, Statistics New Zealand said on Thursday, accelerating from the 4.0 percent gain in November. Individually, fruit and vegetable prices increased 6.9 percent; meat, poultry, and fish prices increased 3.2 percent; grocery food prices increased 4.5 percent; non-alcoholic beverage prices increased 1.7 percent; and restaurant meals and ready-to-eat food prices increased 5.1 percent. On a […]

Record date for dividend is 25 January 2022

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

Glenmark will be responsible for manufacturing and supplying Ryaltris while Lotus will commercialize the drug in the targeted markets. In lieu of this, Glenmark will receive an upfront payment as well as regulatory and sales-based payments from Lotus.

On 11 February 2022

On 2 February 2022